Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer: a population-based study.
A look at the temporal impact of advancements in therapeutic options in the last 10 years-from fluorouracil to irinotecan and oxaliplatin-on overall survival in a population-based cohort.
Lim
Howard J
HJ
Division of Medical Oncology; and Population and Preventive Oncology, British Columbia Cancer Agency, Vancouver; and Division of Medical Oncology, British Columbia Cancer Agency, Victoria, British Columbia, Canada.
Gill
Sharlene
S
Speers
Caroline
C
Melosky
Barbara
B
Barnett
Jeff
J
Fitzgerald
Catherine
C
O'Reilly
Susan
S
Kennecke
Hagen
H